TSX Venture Exchange: NVC
VANCOUVER, Feb. 22, 2012 /PRNewswire/ - Neovasc Inc.(TSXV: NVC), a developer of novel technologies used to treat vascular disease, today announced that the company will participate in the Lazard Capital Markets Annual Medical Technology and Life Sciences/Tools Snowbird Conference. The event is being held at the Snowbird Resort in Snowbird, UTFebruary 29-March 2, 2012.
The conference format consists of one-on-one meetings between participating companies and institutional investors. Investors interested in meeting with Neovasc should contact Lazard Capital Markets directly.
About Neovasc Inc.
Neovasc Inc. is a specialty medical device company that develops,
manufactures and markets products for the rapidly growing
cardiovascular marketplace. Its products include the Neovasc Reducer
for the treatment of refractory angina, the Tiara technology in
development for the transcatheter treatment of mitral valve disease and
a line of advanced biological tissue products that are used as key
components in a variety of third-party medical products, such as
vascular surgical patches and transcatheter heart valves. For more
information, visit: www.neovasc.com.
SOURCE Neovasc Inc.
